Drug metabolism during cholestyramine administration in the rat
Trülzsch, D.; Amler, G.; Mohr, G.; Richter, E.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1656-1659
1975
ISSN/ISBN: 0070-4067 PMID: 1227048 Document Number: 86679
Document emailed within 1 workday
Related Documents
Jones, R.J.; Dobrilovic, L. 1970: Lipoprotein lipid alterations with cholestyramine administration Journal of Laboratory and Clinical Medicine 75(6): 953-966Blom, H.J.; Monasch, E. 1983: Metabolic acidosis in a patient with kidney dysfunction following administration of cholestyramine Nederlands Tijdschrift Voor Geneeskunde 127(32): 1446-1447
Malloy, M.J.; Ravis, W.R.; Pennell, A.T.; Hagan, D.R.; Betagari, S.; Doshi, D.H. 1994: Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics International Journal of Clinical Pharmacology and Therapeutics 32(6): 286-289
Hoogwerf, B.J.; Hibbard, D.M.; Hunninghake, D.B. 1992: Effects of long-term cholestyramine administration on vitamin D and parathormone levels in middle-aged men with hypercholesterolemia Journal of Laboratory and Clinical Medicine 119(4): 407-411
El-Masry S el-D; Mannering, G.J. 1974: Sex-dependent differences in drug metabolism in the rat. II. Qualitative changes produced by castration and the administration of steroid hormones and phenobarbital Drug Metabolism and Disposition: the Biological Fate of Chemicals 2(3): 279-284
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Farrell, G.C.; Cooksley, W.G.; Hart, P.; Powell, L.W. 1978: Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism Gastroenterology 75(4): 580-588
Schwartzkopff, W.; Jantke, H.J. 1980: Changes in beta acetyldigoxin resorption following administration of beta-sitosterine or cholestyramine Die Medizinische Welt 31(33): 1183-1188
von Magnus, M.; Kaaber, K. 1998: Guidelines on drug administration and patient self administration of drugs. Sundhedsstyrelsen (Health Administration) Sygeplejersken 98(9): 32-35
Martines-Maldonado, M.; Stavroulaki-Tsapara, A.; Tsaparas, N.; Suki, W.N.; Eknoyan, G. 1975: Renal effects of lithium administration in rats: alterations in water and electrolyte metabolism and the response to vasopressin and cyclic-adenosine monophosphate during prolonged administration Journal of Laboratory and Clinical Medicine 86(3): 445-461
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Scott, H.; William, E.R. 1997: Suspension of nurse who gave drug on consultant's instructions. Concealed administration of drug treatment may represent thin end of the wedge Bmj 314(7076): 300-301
Urquhart, J. 1984: Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology Bollettino Chimico Farmaceutico 123(4): 155-168
Greene, R.J. 1973: Drug administration. 2. Drug information at ward level Nursing Times 69(31): 992-993
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Lubawy, W.C.; Kostenbauder, H.B.; Stavchansky, S.A. 1974: Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin Research Communications in Chemical Pathology and Pharmacology 8(1): 75-82
Krivoy, N.; Zuckerman, T.; Elkin, H.; Froymovich, L.; Rowe, J.M.; Efrati, E. 2012: Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity Current Drug Safety 7(3): 211-217
Zachrisson, U.; Fürst, C.J. 1995: A survey of drug administration via infusion pumps. Morphine is the most frequently used drug administered by infusion pump Lakartidningen 92(49): 4686-4688
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19